PeptIQ Wiki
The living index of what PeptIQ users track, combine, and report.
Every entry synthesizes cited research and anonymized self-reports into one scannable profile. Browse the full peptide index, preview community scores, and open full reports when you need depth.
- Peptides
- 67
- Reports
- 70,517
- Studies
- 167
- Pairs
- 5
indexed
community
cited
co-stacks
| # | Peptide | Class | Primary use | Dose | Tier | Trend | Score | |
|---|---|---|---|---|---|---|---|---|
| 1 | RetatrutideRetatrutide (LY3437943) is Eli Lilly's triple GLP-1/GIP/glucagon receptor agonist in Phase III clinical trials. The TRIUMPH-4 trial (December 2025) achieved 28.7% average weight loss (71.2 lbs from a 248.5 lb baseline) at 68 weeks with 12mg — the highest weight loss efficacy recorded for any obesity medication to date. FDA approval is anticipated in 2026–2027.GLP-1 & Metabolic | GLP-1 & Metabolic | GLP-1 | 0.5–12 mg weekly | S | 39 | ||
| 2 | TesamorelinTesamorelin (brand: Egrifta SV) is the only FDA-approved GHRH analog, indicated for reduction of excess visceral abdominal fat (lipodystrophy) in HIV-positive adults on antiretroviral therapy. Phase III clinical trials demonstrated significant visceral adipose tissue (VAT) reduction, improved triglyceride profiles, and increased IGF-1 at 2 mg daily dosing. Available by prescription through specialty pharmacies and telehealth.GH Secretagogues | GH Secretagogues | GH | 2 mg once daily | S | 42 | ||
| 3 | GHK-CuGHK-Cu (glycyl-L-histidyl-L-lysine copper) is a naturally occurring tripeptide found in human plasma, saliva, and urine with a high affinity for copper ions. Widely used in dermatology, it has demonstrated the ability to stimulate collagen and elastin synthesis, promote wound healing, activate antioxidant enzymes, and reduce inflammatory skin damage. Commercially available OTC in cosmetic serums, creams, and injectable formulations.Skin & Aesthetics | Skin & Aesthetics | Skin | Topical: varies by formulation (0.1–5%) | S | 55 | ||
| 4 | TirzepatideTirzepatide (Mounjaro for T2D, Zepbound for obesity) is Eli Lilly's FDA-approved dual GLP-1/GIP receptor agonist and the first approved twincretin therapy. SURMOUNT-1 trial demonstrated up to 22.5% average body weight reduction at 72 weeks with 15mg — the highest efficacy among approved obesity medications at time of approval. Also approved for obstructive sleep apnea reduction (2024).GLP-1 & Metabolic | GLP-1 & Metabolic | GLP-1 | 2.5–15 mg weekly | S | 64 | ||
| 5 | MOTS-cMOTS-c is a 16-amino acid mitochondria-derived peptide (MDP) encoded within the 12S rRNA region of the mitochondrial genome — one of only a few proteins known to be encoded by mitochondrial DNA. Early human studies and animal research show it activates AMPK signaling, improves insulin sensitivity, enhances exercise capacity, and reduces age-related metabolic decline. Research only.Mitochondrial | Mitochondrial | Mitochondrial | 5–10 mg weekly (research protocols) | S | 40 | ||
| 6 | SelankSelank is a synthetic heptapeptide anxiolytic based on the immunomodulatory peptide tuftsin (Thr-Lys-Pro-Arg), developed and approved in Russia for generalized anxiety disorder and as an immunomodulator. It demonstrates anxiolytic and nootropic effects comparable to benzodiazepines but without the sedation, dependence potential, or memory impairment. Administered intranasally. Not FDA-approved in the US.Neurological & Cognitive | Neurological & Cognitive | Neurological | 250–500 mcg intranasally 2–3× daily | S | 77 | ||
| 7 | SemaxSemax is a synthetic heptapeptide analog of the ACTH 4-7 fragment extended with Pro-Gly-Pro (PGP) to increase CNS stability and activity. Developed in Russia and approved there for stroke treatment, cognitive enhancement, and neuroprotection. Administered intranasally for direct CNS delivery. Robust Russian clinical literature; not FDA-approved in the US. Widely used as a research nootropic.Neurological & Cognitive | Neurological & Cognitive | Neurological | 200–600 mcg intranasally daily | S | 61 | ||
| 8 | SS-31SS-31 (elamipretide, brand: Bendavia) is a mitochondria-targeted tetrapeptide (D-Arg-2′6′-Dmt-Lys-Phe-NH2) that selectively concentrates in the inner mitochondrial membrane. It has FDA Breakthrough Therapy designation for Barth syndrome and primary mitochondrial myopathy. Phase III trials for heart failure (PROGRESS-HF) and primary mitochondrial myopathy demonstrated significant functional improvements. Not yet FDA-approved for any indication.Mitochondrial | Mitochondrial | Mitochondrial | Clinical trials: 40 mg IV or 40 mg subcutaneous daily | S | 47 | ||
| 9 | BPC-157BPC-157 is a synthetic pentadecapeptide (15 amino acids) derived from a gastric juice protein, researched extensively for accelerating tissue healing, gut repair, and tendon recovery. Animal studies demonstrate dose-dependent healing of tendons, ligaments, bones, muscles, and intestinal tissue, along with anti-inflammatory and angiogenic effects. Not FDA-approved; placed on the FDA's 503A prohibited bulk substances list in 2023.Healing & Recovery | Healing & Recovery | Healing | 250–500 mcg daily | S | 70 | ||
| 10 | TB-500TB-500 is the active synthetic fragment of thymosin beta-4 (Tβ4), a 43-amino acid protein naturally present in virtually all human cells and critical to actin regulation, cell migration, and tissue regeneration. Research shows TB-500 promotes angiogenesis, reduces inflammation, improves tissue flexibility, and accelerates recovery from musculoskeletal injuries. Not FDA-approved; banned from 503A compounding pharmacies.Healing & Recovery | Healing & Recovery | Healing | 2.5–5 mg twice weekly | S | 75 | ||
| 11 | SemaglutideSemaglutide is a GLP-1 receptor agonist developed by Novo Nordisk and FDA-approved as Ozempic (type 2 diabetes, 2017), Wegovy (chronic weight management, 2021), and Rybelsus (oral daily, 2019). STEP 1 clinical trial demonstrated 14.9% average body weight reduction at 68 weeks with 2.4mg weekly. SELECT cardiovascular outcomes trial (2023) showed 20% reduction in major cardiovascular events.GLP-1 & Metabolic | GLP-1 & Metabolic | GLP-1 | 0.25–2.4 mg weekly (injectable); 3–14 mg daily (oral) | S | 38 | ||
| 12 | CJC-1295CJC-1295 is a tetrasubstituted peptide analog of GHRH with a drug affinity complex (DAC) modification — a reactive maleimide group that forms a covalent bond with serum albumin after injection. This dramatically extends its half-life from minutes to 6–8 days, allowing once-weekly dosing with sustained GH and IGF-1 elevation. Available through compounding pharmacies with a prescription.GH Secretagogues | GH Secretagogues | GH | 1–2 mg weekly | S | 78 | ||
| 13 | IpamorelinIpamorelin is a selective pentapeptide growth hormone secretagogue and ghrelin receptor agonist notable for stimulating robust GH release with minimal effect on cortisol or prolactin — making it one of the most selective and well-tolerated GHRP compounds. Frequently combined with CJC-1295 for synergistic GH pulse amplification and sustained IGF-1 elevation. Compoundable with prescription.GH Secretagogues | GH Secretagogues | GH | 200–300 mcg 2–3× daily | S | 70 | ||
| 14 | PT-141PT-141 (bremelanotide, brand: Vyleesi) is FDA-approved for hypoactive sexual desire disorder (HSDD) in premenopausal women. Unlike PDE5 inhibitors, PT-141 acts centrally on melanocortin receptors in the CNS to increase sexual desire and arousal rather than acting peripherally on blood flow. Administered as a subcutaneous autoinjector 45 minutes before anticipated sexual activity. Banned from 503A compounding pharmacies.Sexual Health | Sexual Health | Sexual | 1.75 mg subcutaneous (FDA-approved dose) | S | 63 | ||
| 15 | EpithalonEpithalon (epitalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) based on the natural peptide epithalamin extracted from the pineal gland. Pioneered by Russian researcher Vladimir Khavinson, studies suggest it may stimulate telomerase activity and extend telomere length, regulate melatonin production, and normalize neuroendocrine system function. Mostly animal and limited human aging studies; not FDA-approved.Longevity & Anti-Aging | Longevity & Anti-Aging | Longevity | 5–10 mg daily for 10–20 day cycles | S | 40 | ||
| 16 | SermorelinSermorelin acetate (GHRH 1-29) is a synthetic analog of the first 29 amino acids of endogenous growth hormone-releasing hormone. FDA-approved for diagnosing and treating GH deficiency, it stimulates the pituitary gland to produce and secrete growth hormone naturally — a preferred alternative to exogenous HGH therapy for physiological GH optimization. Available by prescription through compounding pharmacies and telehealth providers.GH Secretagogues | GH Secretagogues | GH | 200–500 mcg nightly | S | 63 | ||
| 17 | AOD-9604AOD-9604 is a modified C-terminal fragment (residues 176–191, Tyr-hGH177-191) of human growth hormone, studied for lipolytic and anti-obesity properties. Unlike full HGH, AOD-9604 lacks growth-promoting or diabetogenic effects but retains the fat-burning activity attributed to HGH's C-terminus. Phase IIb/III trials were conducted for obesity but fell short of the primary endpoint. Research only in the US.GLP-1 & Metabolic | GLP-1 & Metabolic | GLP-1 | 300 mcg daily (research protocols) | S | 67 | ||
| 18 | Thymosin Alpha-1Thymosin alpha-1 (Tα1, brand: Zadaxin) is a 28-amino acid peptide naturally produced by the thymus gland that plays a central role in modulating T-cell maturation and immune response. Approved in 40+ countries for hepatitis B, hepatitis C treatment adjuvancy, and as immune support in cancer patients. In the US, available through compounding pharmacies for immune support. Studied for COVID-19 severity reduction.Immune Support | Immune Support | Immune | 1.6 mg twice weekly (standard); 3.2 mg twice weekly (intensive) | S | 58 | ||
| 19 | IGF-1 LR3IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1) is a recombinant analog of IGF-1 with an Arg3 substitution and a 13-amino acid N-terminal extension. These modifications dramatically reduce binding to IGF-binding proteins (IGFBPs), resulting in a ~20–30 hour half-life (vs. 12–15 hours for native IGF-1) and significantly greater tissue exposure and anabolic potency. Research only; not FDA-approved.GH Secretagogues | GH Secretagogues | GH | 20–100 mcg daily (research protocols) | S | 49 | ||
| 20 | ARA-290Non-erythropoietic peptide studied for neuropathic and inflammatory indications.Neurological & Cognitive | Neurological & Cognitive | Neurological | — | S | 100 | ||
| 21 | AdamaxNootropic research peptide in the Semax-family class; limited direct clinical evidence.Neurological & Cognitive | Neurological & Cognitive | Neurological | — | S | 97 | ||
| 22 | Pentosan PolysulfateHeparinoid compound used clinically in non-peptide indications; sometimes tracked in protocol stacks.Immune Support | Immune Support | Immune | — | S | 94 | ||
| 23 | LiraglutideLiraglutide (Victoza for T2D, Saxenda for obesity) is Novo Nordisk's FDA-approved once-daily injectable GLP-1 receptor agonist. SCALE obesity trial demonstrated 5–8% body weight reduction and significant HbA1c reduction. While largely superseded by once-weekly semaglutide and tirzepatide for weight loss, Liraglutide remains a cornerstone type 2 diabetes treatment and has a robust cardiovascular outcomes trial (LEADER) demonstrating cardiovascular risk reduction.GLP-1 & Metabolic | GLP-1 & Metabolic | GLP-1 | 0.6–1.8 mg daily (Victoza); 0.6–3 mg daily (Saxenda) | S | 92 | ||
| 24 | LL-37LL-37 is the only cathelicidin antimicrobial peptide expressed in humans, derived from cleavage of the C-terminus of hCAP18. It demonstrates broad-spectrum antimicrobial activity against bacteria (including MRSA), fungi, and viruses, and also plays critical roles in wound healing, immune modulation, and anti-tumor activity. Expressed primarily in neutrophils, epithelial cells, and skin. Research only.Antimicrobial | Antimicrobial | Antimicrobial | Research setting (doses not established for humans) | S | 92 | ||
| 25 | PinealonRussian peptide-bioregulator discussed for cognitive and aging-related signaling.Longevity & Anti-Aging | Longevity & Anti-Aging | Longevity | — | S | 91 | ||
| 26 | CagrilintideLong-acting amylin analog studied for obesity and metabolic disease.GLP-1 & Metabolic | GLP-1 & Metabolic | GLP-1 | — | S | 86 | ||
| 27 | 5-Amino-1MQSmall-molecule NNMT inhibitor often discussed with metabolic protocols; investigational.GLP-1 & Metabolic | GLP-1 & Metabolic | GLP-1 | 50–150 mg daily (research only) | S | 86 | ||
| 28 | GHRP-6GHRP-6 is a synthetic hexapeptide growth hormone secretagogue that strongly stimulates GH release through ghrelin receptor activation. It is particularly notable for significantly increasing appetite via ghrelin pathway activation — useful in research contexts for body composition changes, catabolic state reversal, and GH deficiency studies. Research use only; not FDA-approved for therapeutic use.GH Secretagogues | GH Secretagogues | GH | 100–200 mcg 2–3× daily | S | 85 | ||
| 29 | GHRP-2GHRP-2 (pralmorelin) is a synthetic hexapeptide GH secretagogue with stronger GH-releasing potency than GHRP-6 but with less pronounced appetite stimulation. Used in clinical research for GH deficiency diagnosis and studied for body composition effects. It is approved in Japan as a diagnostic agent for GH deficiency (Pralmorelin KM) but not approved for therapeutic use in the US.GH Secretagogues | GH Secretagogues | GH | 100–200 mcg 2–3× daily | S | 85 | ||
| 30 | Melanotan IIMelanotan II (MT-II) is a synthetic analog of α-melanocyte-stimulating hormone (α-MSH) studied for skin tanning, erectile function, and appetite suppression. Not FDA-approved and associated with significant safety concerns including dangerous nausea, uncontrolled melanocytic changes (nevi/moles), hypertension, and priapism. The FDA has issued multiple warnings. Banned from 503A compounding. Use with extreme caution.Sexual Health | Sexual Health | Sexual | Research: 0.5–1 mg (extreme caution; not recommended) | S | 85 | ||
| 31 | TB-500 FragmentTB4-derived fragment used in repair protocols; limited direct human data.Healing & Recovery | Healing & Recovery | Healing | — | S | 84 | ||
| 32 | P21Experimental neurocognitive peptide candidate with limited human evidence.Neurological & Cognitive | Neurological & Cognitive | Neurological | — | S | 84 | ||
| 33 | Follistatin 344Follistatin 344 is an isoform of follistatin (FST), a naturally occurring glycoprotein that binds and neutralizes TGF-β superfamily members, most notably myostatin (GDF-8) and activin A. Animal studies show dramatic and permanent muscle hypertrophy with single gene therapy doses. Human pharmacokinetic and safety data are extremely limited; the risk of irreversible muscular hypertrophy and unknown off-target effects make this highly experimental. Research only — extreme caution advised.Healing & Recovery | Healing & Recovery | Healing | No established safe human dose — research setting only | S | 83 | ||
| 34 | OvagenInvestigational peptide-bioregulator discussed for ovarian/endocrine pathways.Hormonal & Endocrine | Hormonal & Endocrine | Hormonal | — | S | 80 | ||
| 35 | PEG-MGFPEG-MGF (PEGylated mechano growth factor) is a polyethylene glycol-modified variant of the IGF-1 splice variant mechano growth factor (MGF), a local isoform of IGF-1 produced in muscles in response to mechanical loading or injury. PEGylation extends the half-life from minutes to approximately 5 days. Research demonstrates activation of muscle satellite cells and promotion of muscle hypertrophy and repair. Research only.Healing & Recovery | Healing & Recovery | Healing | 200–400 mcg 1–2× weekly (research protocols) | S | 80 | ||
| 36 | NAD+Nicotinamide adenine dinucleotide (NAD+) is an essential coenzyme present in all living cells, central to energy metabolism (cellular respiration), DNA repair, and sirtuins-mediated gene expression regulation. NAD+ levels decline significantly with aging. IV and subcutaneous NAD+ infusion clinics have grown substantially for anti-aging, metabolic health, cognitive support, and addiction recovery. Oral precursors (NMN, NR) are widely available as supplements.Longevity & Anti-Aging | Longevity & Anti-Aging | Longevity | IV: 250–1000 mg infusion; oral NMN: 250–1000 mg daily | S | 79 | ||
| 37 | ITPPExperimental oxygen-delivery/metabolic performance compound tracked in research circles.GLP-1 & Metabolic | GLP-1 & Metabolic | GLP-1 | — | S | 79 | ||
| 38 | Melanotan IAlpha-MSH analog related to afamelanotide pathways; non-indicated tanning use carries risk.Sexual Health | Sexual Health | Sexual | — | S | 79 | ||
| 39 | FOXO4-DRIFOXO4-DRI is a D-amino acid retro-inverso (DRI) peptide designed to disrupt the interaction between the FOXO4 transcription factor and p53 protein that keeps senescent cells (zombie cells) alive. Published mouse studies (Nature 2017) showed that FOXO4-DRI selectively induced apoptosis of senescent cells, improving fitness, coat density, and kidney function. No human clinical trials have been published. Research only; handle with caution.Longevity & Anti-Aging | Longevity & Anti-Aging | Longevity | Mouse studies: 5 mg/kg 3× weekly; human dose not established | S | 78 | ||
| 40 | MK-677Oral ghrelin receptor agonist used in GH-axis research.GH Secretagogues | GH Secretagogues | GH | 10–25 mg daily | S | 76 | ||
| 41 | HumaninHumanin is a 21-amino acid mitochondria-derived peptide encoded within the 16S rRNA region of the mitochondrial genome, discovered in 2001 from a cDNA library of Alzheimer's-resistant brain tissue. Research demonstrates neuroprotective, anti-apoptotic, and metabolic effects. Circulating humanin levels decline significantly with aging. Studied for Alzheimer's disease, diabetes, and cardiovascular protection. Research only.Mitochondrial | Mitochondrial | Mitochondrial | Research setting only (doses not established for humans) | S | 75 | ||
| 42 | RU-58841Topical anti-androgen research compound discussed for hair-loss protocols (non-peptide).Skin & Aesthetics | Skin & Aesthetics | Skin | — | S | 74 | ||
| 43 | GonadorelinGonadorelin is the synthetic form of gonadotropin-releasing hormone (GnRH), a 10-amino acid hypothalamic peptide. FDA-approved for diagnosing hypogonadotropic hypogonadism and evaluating pituitary-gonadal function. Widely used in men on testosterone replacement therapy (TRT) to maintain testicular size, fertility, and endogenous testosterone production by preventing HPG axis suppression. Available through compounding pharmacies.Hormonal & Endocrine | Hormonal & Endocrine | Hormonal | 100 mcg 2–3× weekly subcutaneous (TRT adjunct protocol) | S | 74 | ||
| 44 | Mod GRF 1-29Short-acting GHRH analog used in research protocols for pulsatile GH signaling.GH Secretagogues | GH Secretagogues | GH | 100–200 mcg once or twice daily | S | 73 | ||
| 45 | CagriSemaInvestigational fixed-dose combination of cagrilintide and semaglutide.GLP-1 & Metabolic | GLP-1 & Metabolic | GLP-1 | — | S | 72 | ||
| 46 | SNAP-8Topical cosmetic peptide used in anti-wrinkle formulations.Skin & Aesthetics | Skin & Aesthetics | Skin | — | S | 71 | ||
| 47 | HGH (Somatropin)Human Growth Hormone (somatropin, rhGH) is a recombinant form of endogenous growth hormone used clinically for growth hormone deficiency and selected catabolic conditions. It remains one of the most studied anabolic endocrine therapies, with extensive evidence in pediatric and adult GHD populations and ongoing registry data for long-term outcomes. Off-label use for body composition and anti-aging remains medically controversial and should be physician-supervised.Hormonal & Endocrine | Hormonal & Endocrine | Hormonal | 1-2 IU daily (wellness) to 4-6 IU daily (advanced/off-label); physician protocols vary | S | 69 | ||
| 48 | CDP-CholineCholine donor and nootropic compound used for cognitive and neuro-support protocols (non-peptide).Neurological & Cognitive | Neurological & Cognitive | Neurological | — | S | 67 | ||
| 49 | ClomipheneSERM approved for ovulation induction; used off-label in endocrine/TRT-adjacent protocols.Hormonal & Endocrine | Hormonal & Endocrine | Hormonal | — | S | 65 | ||
| 50 | SLU-PP-332Exercise-mimetic metabolic research compound (non-peptide) explored for endurance pathways.GLP-1 & Metabolic | GLP-1 & Metabolic | GLP-1 | — | S | 64 | ||
| 51 | EnclomipheneSERM used in endocrine protocols to stimulate LH/FSH and endogenous testosterone.Hormonal & Endocrine | Hormonal & Endocrine | Hormonal | — | S | 64 | ||
| 52 | CartalaxInvestigational peptide discussed for cartilage and connective-tissue support.Healing & Recovery | Healing & Recovery | Healing | — | S | 63 | ||
| 53 | DSIPDelta sleep-inducing peptide (DSIP) is a nonapeptide first isolated in 1977 from thalamic perfusate of sleeping rabbits by Monnier et al. that induced slow-wave (delta) sleep when infused. Subsequent research has explored roles in pain modulation, stress response, temperature regulation, and antioxidant effects. Clinical evidence is limited and inconsistent; mechanism remains poorly characterized. Research only.Neurological & Cognitive | Neurological & Cognitive | Neurological | 25–100 mcg (research; no established human dose) | S | 62 | ||
| 54 | OxytocinOxytocin is an FDA-approved 9-amino acid neuropeptide hormone naturally produced in the hypothalamus and released by the posterior pituitary. FDA-approved as Pitocin for labor induction and postpartum hemorrhage. Extensively researched for social bonding, trust, autism spectrum disorder, PTSD, anxiety, and metabolic effects. Intranasal oxytocin is widely studied; availability through compounding pharmacies and telehealth.Hormonal & Endocrine | Hormonal & Endocrine | Hormonal | Intranasal: 20–40 IU; IV: obstetric protocols vary | S | 60 | ||
| 55 | VIPVasoactive intestinal peptide (VIP) is a 28-amino acid neuropeptide naturally expressed throughout the nervous system, gut, and immune tissues. It functions as a potent immunomodulator, bronchodilator, and vasodilator. Clinically researched for inflammatory bowel disease, pulmonary arterial hypertension, sarcoidosis, autoimmune conditions, and CIRS (Chronic Inflammatory Response Syndrome). Available through compounding pharmacies with a prescription.Immune Support | Immune Support | Immune | 50 mcg intranasally twice daily (CIRS protocol) or 200–400 ng/kg IV infusion | S | 58 | ||
| 56 | HexarelinHexarelin (examorelin) is a synthetic hexapeptide GHRP with the highest GH-releasing potency among the GHRP class. Uniquely among GH secretagogues, hexarelin has demonstrated direct cardioprotective effects through CD36 receptor binding that are independent of GH release — making it of research interest for cardiac protection applications. Research use only; not FDA-approved.GH Secretagogues | GH Secretagogues | GH | 100–200 mcg 2–3× daily | S | 54 | ||
| 57 | Collagen PeptidesOral collagen-derived peptides used for skin, hair, nail, and connective-tissue support.Skin & Aesthetics | Skin & Aesthetics | Skin | — | S | 54 | ||
| 58 | CerebrolysinCerebrolysin (FPE 1070) is a porcine brain-derived neuropeptide preparation containing a mixture of neurotrophic peptide fractions including BDNF-, NGF-, CNTF-, and GDNF-like fragments (<10kDa). Approved in Austria, Russia, China, South Korea, and other countries for Alzheimer's disease, post-stroke recovery, and traumatic brain injury. Multiple randomized controlled trials have demonstrated cognitive and functional improvements. Not FDA-approved in the US.Neurological & Cognitive | Neurological & Cognitive | Neurological | 10–30 mL IV infusion daily for 10–20 day courses | S | 53 | ||
| 59 | L-CarnitineAmino-acid derivative used for mitochondrial and metabolic support (non-peptide).Longevity & Anti-Aging | Longevity & Anti-Aging | Longevity | — | S | 50 | ||
| 60 | KPVKPV is the C-terminal tripeptide (Lys-Pro-Val) of alpha-melanocyte stimulating hormone (α-MSH), retaining its potent anti-inflammatory properties without melanocortin receptor-dependent melanization effects. Research demonstrates significant potential for inflammatory bowel disease (IBD), Crohn's disease, skin inflammatory conditions, and wound healing. Oral formulations show promise for gut-specific delivery. Research only.Immune Support | Immune Support | Immune | 500 mcg–2 mg daily (research protocols) | S | 49 | ||
| 61 | KisspeptinNeuropeptide signaling regulator of the GnRH axis, studied for reproductive endocrinology.Hormonal & Endocrine | Hormonal & Endocrine | Hormonal | — | S | 49 | ||
| 62 | DihexaDihexa (PNB-0408, N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is a potent hepatocyte growth factor (HGF) receptor agonist originally developed at Washington State University. Preclinical studies in rodents show it enhances synaptic connectivity and spatial memory retention — with reported potency millions of times greater than BDNF. No published human clinical trials exist. Research only; use with caution.Neurological & Cognitive | Neurological & Cognitive | Neurological | Research protocols: ~1 mg/kg topical or oral (no established human dose) | S | 49 | ||
| 63 | LarazotideTight-junction regulator peptide studied for gut barrier and celiac-associated symptoms.Healing & Recovery | Healing & Recovery | Healing | — | S | 49 | ||
| 64 | BPC-157 StableStabilized oral BPC-157 variant marketed for GI-focused research protocols.Healing & Recovery | Healing & Recovery | Healing | — | S | 47 | ||
| 65 | BPC-157 (Oral)Oral BPC-157 formulation discussed for GI-first protocols; evidence remains limited.Healing & Recovery | Healing & Recovery | Healing | — | S | 45 | ||
| 66 | CJC-1295 (no DAC)Short-acting CJC/GRF variant used for pulse-style GH protocols.GH Secretagogues | GH Secretagogues | GH | — | S | 42 | ||
| 67 | GlutathioneEndogenous tripeptide antioxidant used across wellness and clinical protocols.Longevity & Anti-Aging | Longevity & Anti-Aging | Longevity | — | S | 35 |
Showing 67 of 67 indexed peptides
Deep dives: Research index · Trends · Compare
Observational reporting — not medical advice.